Position/Title: Consultant Neurologist, Assistant Professor

Address: University of Lübeck; Ratzeburger Allee 160, 23538 Lübeck, Germany

Tel: +49-451-50043420; Fax:+49-451-50043424




1998-2005 Medical school (Lübeck, Luzern)

2001-2005 Doctoral thesis (Prof. P. Dominiak, Department of Experimental Pharmacology and Toxicology, University of Lübeck, Germany)

2005-2011 Neurogenetics Research Fellow (Prof. C. Klein, Section of Clinical and Molecular Neurogenetics, University of Lübeck, Germany)

2011-2013 Postdoctoral fellow (Prof. H. Siebner, Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, Denmark)

2012 Habilitation in Neurogenetics (University of Lübeck, Germany)

2013-2014 Medical residency (Dept. of Neurology, University of Lübeck, Germany)

2012-present Assistant Professor in Neurogenetics

2014-present Neurology Consultant (Dept. of Neurology, University of Lübeck, Germany)


2011-present Ad hoc reviewer for JNNP, Movement Disorders, Medicine, BMC Neuroscience, Parkinsonism and Related Disorders, European Journal of Medical Genetics, European Journal of Neurology, Neuroimage

2005-present Member of the German Neurological Society (DGN)

2008-present International Parkinson and Movement Disorder Society (MDS)

2011-present Member of the Study group ‘Botulinum toxin’ of the German Society of Neurology

2011-present Member of the German Society for Clinical Neurophysiology and Functional Imaging (DGKN)

2013-present American Academy of Neurology (AAN)


2002-2005 Scholarship of the German Catholic Academic Foundation „Cusanuswerk“

2006 University Award of the Medical Faculty, University of Lübeck

2008 Travel award from the Movement Disorder Society

2009 Travel award from the American Academy of Neurology

2010 Travel award from the American Academy of Neurology

2011 International Research Fellowship from the DFG

2011 Travel award from the Movement Disorder Society

2012 Travel award from the Movement Disorder Society

2012 Junior Research Award of the Movement Disorder Society


From 90 original publications; total citations: 1,472; h-index: 25

    1. Brüggemann N, Odin P, Gruenewald A, …, Djarmati A. De novo a-Synuclein duplication as cause of sporadic early onset parkinsonism. Neurology 2008;71(16):1294. (IF: 7.0)
    1. Brüggemann N, Kock N, Lohmann K, …, Klein C. The D216H variant in the DYT1 gene – a susceptibility factor for dystonia in familial cases? Neurology 2009;72(16):1441-3. (IF: 8.2)
    1. Djarmati A, Schneider SA, Lohmann K, …, Brüggemann N, …, Klein C. Mutations in THAP (DYT6) and generalized dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol 2009;8(5):447-52. (IF: 18.1)
    1. Brüggemann N, Hagenah J, Reetz K, …, Klein C. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch Neurol 2010;67(11):1357-63. (IF: 7.1)
    1. Hagenah J, König IR, Sperner J, …, Brüggemann N. Life-long increase of substantia nigra hyperechogenicity in transcranial sonography. Neuroimage 2010;51(1):28-32. (IF: 5.9)
    1. Brüggemann N, Hagenah J, Stanley K, …, Saunders-Pullman R. Substantia nigra hyperechogenicity with LRRK2 G2019S mutations. Mov Disord 2011;26(5):885-8. (IF: 4.5)
    1. Brüggemann N, Spiegler J, Hellenbroich Y, …, Klein C. Beneficial prenatal levodopa therapy in autosomal recessive GTP cyclohydrolase I deficiency. Arch Neurol 2012;69(8):1071-5. (IF: 7.0)
    1. Lohmann K, Wilcox RA, Winkler S, …, Brüggemann N, …, Klein C (2013) Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene. Ann Neurol 2013;73(4):537-45. (IF: 11.9)
    1. Herz D, Christensen M, Brüggemann N, …, Siebner H. Motivational tuning of fronto-subthalamic connectivity facilitates control of action impulses. J Neurosci 2014; 34(9):3210-7. (IF: 6.3)
    1. Brüggemann N, Kühn A, Schneider SA, …, Klein C. Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology 2015;84(9):895-903. (IF: 8.3)